If you are a Nurse Practitioner or are planning to become one, keeping your expanded practice up-to-date is essential. Attend this conference and learn about the latest trends influencing prescribing and practice. It includes:
Don’t miss out! Book now!
Drug interactions require a triage approach. When do you need to make a fuss? This session will discuss the detection, prediction and prevention of drug interactions and includes:
This session will highlight the issues surrounding the prescription of antidepressants. Moreover, it will demonstrate how to overcome these issues to achieve safe and effective pharmacotherapeutic outcomes. It includes:
Nurse practitioners play a key role in the management of chronic non-cancer pain. This key session will:
Patient outcomes require that Nurse Practitioners are familiar with current treatment options for asthma. This session will focus on providing an evidenced update for the treatment of asthma, with a brief look at allergic rhinitis and aspirin-induced respiratory disease. It includes a review of current medications used in asthma. Discuss:
Breakout Room One – Allergies
Many patients are falsely labelled with a penicillin allergy either because their allergy has gone or they weren’t allergic in the first place. “Fake” penicillin allergies lead to inappropriate use of non-penicillin antibiotics, higher healthcare costs and contribute to antimicrobial resistance. What is the up-to-date pathway for managing patients who claim to penicillin or other antibiotic allergies? This session will discuss:
Breakout Room Two – Opioid Epidemic
The opioid crisis rocking North America has led to widespread international coverage. What is the current state of play in Australia? This session will bring you up to speed on the topic and will:
Breakout Room Three – Gout
Gout is a common inflammatory condition within joints. Gout is often considered “unimportant” and is associated with many myths and misconceptions. This session provides a practical approach to the management of gout. The session topics include:
The benefits of low-dose aspirin use for secondary prevention of cardiovascular disease is well established. Up until recently, mixed data leaned toward a benefit for primary prevention as well. This presentation will discuss the results of three recent large-scale trials that indicate a greater harm than benefit for initiating aspirin treatment in older adults for primary prevention. Session objectives include:
This opening session provides essential tips on how to find and utilise the most up-to-date and credible information on medicines to ensure you are making informed therapeutic decisions. It includes:
The prescribing of potentially inappropriate medicines (PIMs) to older people is a serious concern. Continuing to use medicines when there is poor evidence of a benefit, places older people and the prescriber at great risk. This session is based on a case presentation and will address:
Breakout Room One - Paediatrics
Prescribing medicines for children takes into account many factors. This session will review paediatric prescribing decision-making and focus on:
Breakout Room Two – Diabetes
While some of the management of diabetes may be initially possible through changes to lifestyle, treatment with medication is usually required. This session reviews the new types of glucose-lowering medicines that are currently used to diabetes mellitus and includes:
Breakout Room Three – Liver Disease
A significant number of Australians are living with chronic liver disease and may experience variable changes in drug metabolism and elimination. Understanding the implications is essential for prescribers to ensure medication safety. This session discusses:
Breakout Room One – COPD
Inhaled therapy forms the cornerstone of maintenance pharmacotherapy for COPD. Inhaler options have expanded rapidly with new medicines, generics of old drugs, new devices and combinations with two and three drug classes. Greater choice is welcomed but when prescribed without a coherent framework for selection, the complexity can lead to confusion for clinicians and patients and worse outcomes. This session will:
Breakout Room Two – Pregnancy
This session looks at the key concepts and challenges for safe prescribing during pregnancy and lactation. It includes:
Breakout Room Three – Diabetes
This practical workshop will review three complex case studies. Collaboratively, you will work through situations that require key pharmacology and prescribing considerations. It includes the following scenarios:
Most tattoo-related health and safety guidance centres on hygiene and the prevention of infections. Despite the increase in popularity, little consideration is given to the toxicological risks of ingredients used in tattoos. This final session reveals:
Debbie Rigby is a consultant clinical pharmacist from Brisbane. Since graduation with a Bachelor of Pharmacy from the University of Queensland, she has since obtained a graduate diploma in clinical pharmacy, certification in geriatric pharmacy, an advanced diploma in nutritional pharmacy, certification as an asthma educator, and she has become credentialed as an advanced practice pharmacist. Debbie is a director on the NPS MedicineWise Board; clinical reference lead to Australian Digital Health Agency; a member of the Veterans’ MATES Practitioner Reference Group, Australian Deprescribing Network; visiting fellow at QUT; and an adjunct senior lecturer at the University of Queensland. Debbie conducts home medicine reviews in collaboration with GPs in a medical centre and provides education to pharmacists, GPs, nurses, Nurse Practitioners and consumers. Debbie was the inaugural recipient of the AACP Consultant Pharmacist Award in 2008 and was awarded the 2001 PSA Australian Pharmacist of the Year, the PSA Qld Bowl of Hygeia in 2002 and the SHPA 2016 Australian Clinical Pharmacy Award. Last year, Debbie was voted the most influential woman in pharmacy.
John Serginson has been a nurse practitioner: respiratory care at the Caboolture Hospital since 2010. He completed his nurse practitioner master's degree at the University of Queensland (UQ) with clinical training at The Prince Charles Hospital. He is an adjunct lecturer in the UQ School of Nursing and Midwifery. With 29 years’ experience as a nurse (16 in respiratory care), his research interests include domiciliary oxygen, inhaled therapy and COPD models of care.
Dr Geraldine Moses is a doctor of clinical pharmacy, specialising in drug information. She is currently based part-time at the Mater Hospital in Brisbane where she works in the Academic Practice Unit and in aged care. She is a guest lecturer at the University of Queensland and Queensland University of Technology, contributing to training in schools of pharmacy, medicine, dentistry, nursing and optometry. She consults for organisations, such as the Australian Dental Association (Qld branch), the Department of Veterans Affairs, the Optometrists Association and the Rural Health Education Foundation.
Dr Treasure McGuire is a medicines information pharmacist, pharmacologist, educator and researcher. As assistant director of pharmacy, Mater Health Services, she manages their academic practice unit. She is also a senior conjoint lecturer in the School of Pharmacy, University of Queensland and associate professor of pharmacology, Faculty of Health Sciences & Medicine, Bond University, where she lectures on complementary medicines, reproductive health, medication safety and communicable diseases. In recognition of her services to medicines information, she received the Lilly International Fellowship in Hospital Pharmacy and the Bowl of Hygeia of the Pharmaceutical Society of Australia.
Joyce McSwann is a multi-award winning clinical pharmacist with a special interest in treating persistent pain. Currently, she is the clinical program director of the Gold Coast Primary Health Network, Persistent Pain Program, Australia’s first federally funded primary health multidisciplinary pain program, which she founded in 2013. She was recently named Australian’s No 1 Agenda Setter by the readership of the Australian Journey Pharmacy and is the current QLD Board director of the Australian Pain Society. Some of her more recent appointments include being an expert panel member of the Chronic Pain Medscheck Trial Program and chair of the Pharmacology Program in the 2019 Australian Pain Society’s Scientific Conference. Joyce is a member of the International Association of the Study of Pain, and her expertise lies in innovating clinical pathways within the public and private primary health sectors. She is also the founder and managing director of the PainWISE Pharmacy Professional Services program, Australia’s first multidisciplinary clinical pain program for the pharmacy industry. Her work focuses on translating clinical evidence to everyday practice and optimise care for those living with noncommunicable diseases.
Kelly Hayward is a clinical pharmacist and clinician researcher at the Princess Alexandra Hospital. She was awarded her PhD in 2019 for her work in hepatology ambulatory care to reduce preventable harm due to medication-related problems in people with decompensated cirrhosis. She is a passionate advocate for collaborative interdisciplinary care to improve medication safety and health outcomes for people with chronic liver disease.
Nurse Practitioners are authorised to prescribe a wide range of medicines. This demands a high-level of knowledge and skills relating to pharmacotherapeutic action, including potential adverse and other side effects, drug interactions, compliance and evaluation. Therapeutic decisions must be based on evidenced knowledge about medical conditions. Nurse Practitioners are required to access 30 hours of education per year, including 10 hours relating to their advanced practice and prescribing. The sheer amount of new evidence about medicines today makes it essential for prescribers to stay adequately informed.
The purpose of this program is for Nurse Practitioners or advanced practice nurses to increase knowledge and keep up-to-date about prescribing, the administration of medicines and professional practice.
If you can’t find your event, but haven’t heard from us yet - don’t worry! Our Customer Experience team is working hard to contact all 2021 event attendees. Keep an eye out for an email from us!
You can speak with us directly via 1300 287 633 or email firstname.lastname@example.org
In the meantime, why not learn online instead? Start an Ausmed Subscription you’ll get access to 100s of high-quality online resources, including lectures from our top-rated events!Start my Subscription